Viewing Study NCT02242227


Ignite Creation Date: 2025-12-25 @ 5:06 AM
Ignite Modification Date: 2026-03-02 @ 6:24 PM
Study NCT ID: NCT02242227
Status: COMPLETED
Last Update Posted: 2014-09-17
First Post: 2014-09-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy, Pharmacokinetics and Safety Comparison of Salmeterol Inhalation Powder Administered Via the HandiHaler® 2 and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module